ISRG vs BMY
Intuitive Surgical · Bristol-Myers Squibb
| ISRG Intuitive Surgical Healthcare | BMY Bristol-Myers Squibb Healthcare | |
|---|---|---|
| Market | ||
| Price | $432.01 -3.73% | $62.48 +1.78% |
| Market cap | $149.8B | $127.6B |
| P/E (TTM) | 50.6 | 13.8 |
| Dividend yield | — | 4.58% |
| 52-week range | $328.57 – $603.88 | $43.20 – $68.64 |
| Our research | ||
| Our view | LONG open | LONG open |
| Articles | 1 | 1 |
| Latest article | Intuitive Surgical (ISRG): Non-GAAP EPS Up 25%, GAAP EPS Down 24%, And A $450M Settlement… Nov 1, 2026 | Bristol-Myers Squibb: The Forensic Case That The Patent Cliff Math Has Already Been Solved May 27, 2026 |
| Latest earnings | ||
| Reported | Oct 20, 2026 | Oct 29, 2026 |
| Revenue | $3.05 billion +22% YoY | $13.1 billion +7% YoY |
| EPS | $0.99 | $1.05 |
| Guidance | Guidance issued | Guidance raised |
| Revenue growth, last 4 reports | +22% | +7% |
| Topics | ||
| Main topics | ||
| Company page · Earnings releases | Company page · Earnings releases | |
Note. Earnings figures are extracted automatically from each company's own release; prices are delayed up to 15 minutes. This comparison is information, not investment advice.